Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

P. Pacher, L. Liaudet, Jon Mabley, K. Komjati, C. Szabo

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences